Project Grant R01HL173153
Award Date
8/1/25
Completion Date
5/31/29
Dollars Obligated
$501K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) aims to develop novel statistical models for multi-trait analysis in large-scale biobank datasets linked to electronic health records. The $122,234 award, effective from September 20, 2024 to August 31, 2026, will support research at Columbia University's Health Sciences Division to enhance disease association mapping and risk prediction accuracy. Specifically, the project will: 1)...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), will fund a study on the early life predictors of airway-to-lung mismatch, a condition known as dysanapsis. The primary awardee, The Trustees of Columbia University in the City of New York, will receive $753,018 to leverage longitudinal data from 8 diverse birth cohorts to examine the relationship between early-life exposures, such...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $641,544 to the University of North Carolina at Chapel Hill to develop enhanced machine learning tools for complex data evaluation and integration in advancing health outcomes related to heart, lung, blood, and sleep (HLBS) disorders. The project aims to: 1) propose novel machine learning methods for adjusting complex confounding...
This $131,988 Project Grant from the National Heart, Lung and Blood Institute, part of the Department of Health and Human Services, supports research targeting determinants of SARS-CoV-2 host interaction in airways. Funded through the Cardiovascular Diseases Research program, the grant aims to identify master regulator proteins that mechanistically regulate SARS-CoV-2 interactions in the airways. Using organotypic airway epithelial culture and systems biology tools at Columbia University, the...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $829,103 to The Trustees of Columbia University in the City of New York to conduct research on functional coagulation and hemostasis after intracerebral hemorrhage (ICH). The goal is to perform a multimodal assessment of coagulation in ICH patients using traditional clinical assays, contemporary whole blood viscoelastic hemostatic assays,...
This Project Grant award of $2,369,201, provided by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research), aims to develop a population-based analytics and data infrastructure to evaluate the impact of non-COPD medications on outcomes for patients with Chronic Obstructive Pulmonary Disease (COPD). The overarching goal is to leverage existing claims data and electronic health records, including data from the COPDGene cohort study, to identify potential...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Federal Grant Program for Cardiovascular Diseases Research (CFDA 93.837), provides $123,104 to Emory University to conduct research on factors contributing to cardiovascular disease (CVD) comorbidities in persons living with HIV (PWH). The key objectives are to: 1) assess relationships between the metabolome, lipidome, HIV reservoir, and subclinical CVD, analyzing differences by sex; and 2) determine...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $299,604 to Case Western Reserve University to develop and validate a novel transfer volume regression model. This model aims to enable quantitative clinical risk predictions for major cardiovascular events, including stroke, heart attack, heart failure, and death. The project will leverage commonly used, low-cost screening programs to...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) totaling $503,637 will fund research to investigate the mechanisms leading to thrombotic events and microclot formation in patients with COVID-19 infection. The research aims to identify novel regulatory mechanisms that contribute to hemostatic and fibrinolytic dysfunction, which can result in the formation of stable microclots that block blood flow and cause...
This federal Project Grant award, totaling $753,813 and provided by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), supports research to develop novel machine learning techniques for predicting cardiovascular outcomes in patients with clonal hematopoiesis of indeterminate potential (CHIP). The key goals are to use cardiac MRI imaging and genomic data to: 1) Develop a machine learning model to accurately identify CHIP patients and predict their risk...